ANGLE plc (LON:AGL – Get Free Report)’s stock price was up 9.4% during trading on Tuesday . The stock traded as high as GBX 16.25 ($0.21) and last traded at GBX 16 ($0.20). Approximately 3,922,269 shares changed hands during mid-day trading, an increase of 42% from the average daily volume of 2,759,141 shares. The stock had previously closed at GBX 14.63 ($0.19).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 70 ($0.90) price objective on shares of ANGLE in a research note on Wednesday, April 24th.
View Our Latest Report on ANGLE
ANGLE Stock Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Read More
- Five stocks we like better than ANGLE
- Quiet Period Expirations Explained
- Sales Breakout Sends This Semiconductor Stock to Record High
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Surprise Buying Opportunity on This Dividend Aristocrat
- What Does Downgrade Mean in Investing?
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.